What is the recommended dosing, titration, and monitoring for fludrocortisone acetate 0.05 mg oral tablet in patients needing mineralocorticoid replacement?

Fludrocortisone Acetate Dosing and Management

Start fludrocortisone at 0.05-0.1 mg once daily in the morning for adults with primary adrenal insufficiency, titrating up to a maximum of 0.2 mg daily based on clinical response, with the goal of achieving normal blood pressure without orthostasis, normal electrolytes, and plasma renin activity in the upper normal range. 1

Initial Dosing

• Adults and adolescents: 0.05-0.2 mg once daily, typically starting at 0.05-0.1 mg 1
• Children: 100 mcg daily (dose does NOT require adjustment for body surface area and often remains stable throughout life) 1
• Infants (especially <6 months): Require additional sodium chloride supplementation of 1-2 g/day (17-34 mmol/day) divided across feedings due to mineralocorticoid resistance in immature kidneys 1

Timing: Administer once daily in the morning, as aldosterone follows a circadian rhythm similar to cortisol with peak levels in the morning 1

Titration Strategy

The dose is highly individualized based on fluid/electrolyte intake and losses. Titrate based on the following hierarchy:

1. Clinical symptoms: Salt craving, postural dizziness/hypotension, or peripheral edema 1
2. Blood pressure: Measure sitting AND standing to detect orthostatic hypotension 1
3. Electrolytes: Aim for normal sodium and potassium 1
4. Plasma renin activity: Target the upper normal range (this is the most objective marker) 1, 2

Dose adjustments needed in specific situations:

• Hot climate/excessive sweating: Increase dose by 50-100% temporarily OR increase salt intake 1
• Prednisolone users: Require MORE fludrocortisone than hydrocortisone users (prednisolone has less mineralocorticoid activity) 1
• Dexamethasone users: Require FULL mineralocorticoid replacement (dexamethasone has NO mineralocorticoid activity) 1

Monitoring Protocol

Primary monitoring relies on clinical assessment 1:

• At each visit, assess:

  • Salt craving or light-headedness
  • Blood pressure (sitting and standing positions)
  • Peripheral edema (though low sensitivity)
  • General well-being
  • Serum sodium and potassium

• Plasma renin activity: Aim for upper normal range—this is the most useful objective marker for correct dosing 1, 2

• Infants: Require assessment every 3-4 months minimum to monitor growth, blood pressure, and general well-being; mineralocorticoid sensitivity increases over the first year of life, making blood pressure monitoring especially critical 1

Management of Hypertension

If hypertension develops while on fludrocortisone:

1. First: Reduce fludrocortisone dose 1
2. Also evaluate: Glucocorticoid dose (overtreatment with either can cause hypertension) 1
3. If hypertension persists after dose adjustment and patient is euvolemic:
   • First-line: ACE inhibitors or angiotensin II receptor blockers 1
   • Second-line: Dihydropyridine calcium channel blockers 1
   • AVOID: Diuretics 1
   • CONTRAINDICATED: Aldosterone receptor blockers (spironolactone, eplerenone) 1

Critical Drug Interactions and Precautions

Avoid or use with caution:

• Licorice and grapefruit juice: Potentiate mineralocorticoid effect of hydrocortisone—should be avoided 1
• Phenytoin: Increases fludrocortisone metabolism, requiring higher replacement doses 1

Important safety considerations 3:

• Monitor serum electrolytes periodically during prolonged therapy
• Dietary salt restriction and potassium supplementation may be necessary
• Advise patients NOT to restrict salt intake 1
• The medication has marked sodium retention effects—careful monitoring prevents hypertension, edema, and weight gain 3

Common Pitfalls

1. Under-replacement: Many patients remain under-replaced despite treatment, with persistent salt craving and postural symptoms 4. Recent data suggest targeting plasma renin in the upper normal range helps optimize dosing 2.

2. Ignoring glucocorticoid contribution: Hydrocortisone has significant mineralocorticoid activity; patients on higher hydrocortisone doses may need less fludrocortisone 5.

3. Over-reliance on electrolytes alone: Normal electrolytes don't guarantee adequate replacement—clinical symptoms and plasma renin are equally important 1, 6.

4. Long-term dosing: Evidence suggests fludrocortisone dose may be reduced in long-term follow-up (>60 months), particularly in patients with low-normal renin 2.